# Meta-signatures single base substitutions
Meta-mutational signatures, or meta-signatures for short, are signatures of signatures. That is, they describe mutational signatures that typically go together in a sample. Those reported below are based on the COSMIC v3.3 single base substitution signatures and are inferred using the multinomial belief network.

## $M_1$
$M_1$ describes primarily the co-occurrence of replicative DNA polymerase ε damage (SBS10a, SBS10b, and SBS28) with mismatchrepair deficiency (SBS15 and SSB21).
![Meta signature M1](figs/meta_signatures/M1_meta.svg)
![Spectrum of meta signature M1](figs/meta_signatures/M1_spectrum.svg)


## $M_2$
Meta-signature $M_2$ primarily captures, presumably, oxidative stress. Both SBS17a/b and SBS18 are thought to be related to DNA oxidation of guanine leading to 8-Oxo-2’-deoxyguanosine; SBS18 is
additionally linked to hydroxyl radicals in culture. Similar
to clock-like signature SBS1 (describing spontaneous deamination of 5-methylcytosine), damage due to 8-oxodG accumulates in the course of life. To a lesser extent, $M_2$ also captures SBS8, which is believed to
be (uncorrected) replication errors.
![Meta signature M2](figs/meta_signatures/M2_meta.svg)
![Spectrum of meta signature M2](figs/meta_signatures/M2_spectrum.svg)

## $M_3$
Meta-signature $M_3$ describes signatures with a strong transcriptional strand bias (SBS5, SBS8, SBS12, SBS16, SBS92, and SBS22) with the exception of SBS40. Its primary constituent SBS12 is believed to be related to transcription-coupled nucleotide excision repair. The
second largest contributor, SBS40, is a spectrally flat, latereplicating, signature with spectral similarities to SBS5
(both are related to age) and is believed to be linked
to SBS8. According to COSMIC, some contamination
between SBS5 and SBS16 may be present; $M_3$ is
consistent with this observation. Finally, $M_3$ also captures the
co-occurrence with SBS22, which is canonically attributed to
aristolochic acid exposure.

![Meta signature M3](figs/meta_signatures/M3_meta.svg)
![Spectrum of meta signature M3](figs/meta_signatures/M3_spectrum.svg)

## $M_4$
$M_4$ describes the co-occurrence of several, seemingly disparate, mutational signatures of known and unknown aetiology. Of known cause are, SBS7b, linked to ultraviolet light (catalysing cyclobutane pyrimidine dimer formation), SBS87 to thiopurine chemotherapy exposure (although its presence has been reported in a thiopurine-naive lung cancer population) and SBS88, related to colibactin-induced damage from the Escherichia
coli bacterium (found in mouth cancer and in
normal and cancerous colon tissue). Concurrently,
$M_4$ comprises SBS12, SBS23, SBS37, SBS39 and SBS94, all of unknown cause.

![Meta signature M4](figs/meta_signatures/M4_meta.svg)
![Spectrum of meta signature M4](figs/meta_signatures/M4_spectrum.svg)


## Remaining meta signatures $M_5$ - $M_{41}$
For completeness, we list all 37 other meta signatures. Those reported below are the remaining meta-signatures with a non-zero activity, but where the Jensen-Shannon distance fell below 0.25 for at least one signature. Beware, while
completely inactive meta signatures were pruned, some remained with a very small topic activity throughout the dataset (to
wit, $M_{23}$, $M_{26}$, $M_{35}$, $M_{37}$ - $M_{40}$).
![Meta signature M5](figs/meta_signatures/M5_meta.svg)
![Spectrum of meta signature M5](figs/meta_signatures/M5_spectrum.svg)

![Meta signature M6](figs/meta_signatures/M6_meta.svg)
![Spectrum of meta signature M6](figs/meta_signatures/M6_spectrum.svg)

![Meta signature M7](figs/meta_signatures/M7_meta.svg)
![Spectrum of meta signature M7](figs/meta_signatures/M7_spectrum.svg)

![Meta signature M8](figs/meta_signatures/M8_meta.svg)
![Spectrum of meta signature M8](figs/meta_signatures/M8_spectrum.svg)

![Meta signature M9](figs/meta_signatures/M9_meta.svg)
![Spectrum of meta signature M9](figs/meta_signatures/M9_spectrum.svg)

![Meta signature M10](figs/meta_signatures/M10_meta.svg)
![Spectrum of meta signature M10](figs/meta_signatures/M10_spectrum.svg)

![Meta signature M11](figs/meta_signatures/M11_meta.svg)
![Spectrum of meta signature M11](figs/meta_signatures/M11_spectrum.svg)

![Meta signature M12](figs/meta_signatures/M12_meta.svg)
![Spectrum of meta signature M12](figs/meta_signatures/M12_spectrum.svg)

![Meta signature M13](figs/meta_signatures/M13_meta.svg)
![Spectrum of meta signature M13](figs/meta_signatures/M13_spectrum.svg)

![Meta signature M14](figs/meta_signatures/M14_meta.svg)
![Spectrum of meta signature M14](figs/meta_signatures/M14_spectrum.svg)

![Meta signature M15](figs/meta_signatures/M15_meta.svg)
![Spectrum of meta signature M15](figs/meta_signatures/M15_spectrum.svg)

![Meta signature M16](figs/meta_signatures/M16_meta.svg)
![Spectrum of meta signature M16](figs/meta_signatures/M16_spectrum.svg)

![Meta signature M17](figs/meta_signatures/M17_meta.svg)
![Spectrum of meta signature M17](figs/meta_signatures/M17_spectrum.svg)

![Meta signature M18](figs/meta_signatures/M18_meta.svg)
![Spectrum of meta signature M18](figs/meta_signatures/M18_spectrum.svg)

![Meta signature M19](figs/meta_signatures/M19_meta.svg)
![Spectrum of meta signature M19](figs/meta_signatures/M19_spectrum.svg)

![Meta signature M20](figs/meta_signatures/M20_meta.svg)
![Spectrum of meta signature M20](figs/meta_signatures/M20_spectrum.svg)

![Meta signature M21](figs/meta_signatures/M21_meta.svg)
![Spectrum of meta signature M21](figs/meta_signatures/M21_spectrum.svg)

![Meta signature M22](figs/meta_signatures/M22_meta.svg)
![Spectrum of meta signature M22](figs/meta_signatures/M22_spectrum.svg)

![Meta signature M23](figs/meta_signatures/M23_meta.svg)
![Spectrum of meta signature M23](figs/meta_signatures/M23_spectrum.svg)

![Meta signature M24](figs/meta_signatures/M24_meta.svg)
![Spectrum of meta signature M24](figs/meta_signatures/M24_spectrum.svg)

![Meta signature M25](figs/meta_signatures/M25_meta.svg)
![Spectrum of meta signature M25](figs/meta_signatures/M25_spectrum.svg)

![Meta signature M26](figs/meta_signatures/M26_meta.svg)
![Spectrum of meta signature M26](figs/meta_signatures/M26_spectrum.svg)

![Meta signature M27](figs/meta_signatures/M27_meta.svg)
![Spectrum of meta signature M27](figs/meta_signatures/M27_spectrum.svg)

![Meta signature M28](figs/meta_signatures/M28_meta.svg)
![Spectrum of meta signature M28](figs/meta_signatures/M28_spectrum.svg)

![Meta signature M29](figs/meta_signatures/M29_meta.svg)
![Spectrum of meta signature M29](figs/meta_signatures/M29_spectrum.svg)

![Meta signature M30](figs/meta_signatures/M30_meta.svg)
![Spectrum of meta signature M30](figs/meta_signatures/M30_spectrum.svg)

![Meta signature M31](figs/meta_signatures/M31_meta.svg)
![Spectrum of meta signature M31](figs/meta_signatures/M31_spectrum.svg)

![Meta signature M32](figs/meta_signatures/M32_meta.svg)
![Spectrum of meta signature M32](figs/meta_signatures/M32_spectrum.svg)

![Meta signature M33](figs/meta_signatures/M33_meta.svg)
![Spectrum of meta signature M33](figs/meta_signatures/M33_spectrum.svg)

![Meta signature M34](figs/meta_signatures/M34_meta.svg)
![Spectrum of meta signature M34](figs/meta_signatures/M34_spectrum.svg)

![Meta signature M35](figs/meta_signatures/M35_meta.svg)
![Spectrum of meta signature M35](figs/meta_signatures/M35_spectrum.svg)

![Meta signature M36](figs/meta_signatures/M36_meta.svg)
![Spectrum of meta signature M36](figs/meta_signatures/M36_spectrum.svg)

![Meta signature M37](figs/meta_signatures/M37_meta.svg)
![Spectrum of meta signature M37](figs/meta_signatures/M37_spectrum.svg)

![Meta signature M38](figs/meta_signatures/M38_meta.svg)
![Spectrum of meta signature M38](figs/meta_signatures/M38_spectrum.svg)

![Meta signature M39](figs/meta_signatures/M39_meta.svg)
![Spectrum of meta signature M39](figs/meta_signatures/M39_spectrum.svg)

![Meta signature M40](figs/meta_signatures/M40_meta.svg)
![Spectrum of meta signature M40](figs/meta_signatures/M40_spectrum.svg)

![Meta signature M41](figs/meta_signatures/M41_meta.svg)
![Spectrum of meta signature M41](figs/meta_signatures/M41_spectrum.svg)